The question is what that does to GLP-1
The potential beneficial effects of semaglutide (and presumably other GLP1R agonizts) in the treatment of CUD deserve attention in that currently there are no approved medications for its treatment [44]
Acknowledgements We thank the School of Biomedical Sciences and CHIRI for financial support and excellent research facilities, respectively
During exercise, the muscle signals its energy requirements to the liver by changing the concentration of acylcarnitine in the blood, and the liver adjusts its metabolic activity to increase the synthesis and release of energy substances [223, 224], support muscle contraction and meet the energy demands of exercise [225, 226]
It may cause side effects, such as nausea, vomiting, diarrhea, and constipation
It is worth understanding what each category actually means